Activity Dates: 09/28/2023 - 03/31/2024
BCPPs desiring a case-based learning activity at the specialist level focused on a complex patient case intertwined with comorbid medical diagnosis and contemporary issues in psychiatric pharmacy are the intended audience of this recertification activity. The activity design allows for the opportunity to apply evidence-based pharmacological and/or nonpharmacological treatment strategies and monitoring recommendations specific to patient needs and their pertinent medical, psychosocial, family, cultural and socioeconomic issues. BCPPs who are auditory and visual learners and/or who learn best from practical application to a patient case mirroring real-life scenarios will find value in this course. BCPPs responsible for teaching/precepting others also note the value of this product long after completing it for their personal learning.
This application-based BCPP Recertification product provides the opportunity to study a complex psychiatric case comorbid with a medical diagnosis and associated complex medication regimen. A patient is followed over three encounters with each one consisting of a case study, pre-recorded webinar, and self-assessment questions. This edition is focused on bipolar disorder.
The activity design allows for the opportunity to apply evidence-based pharmacological and/or nonpharmacological treatment strategies and monitoring recommendations specific to patient needs and their pertinent medical, psychosocial, family, cultural and socioeconomic issues. Instructional webinars extend the value of the activity long after completion.
The From Theory to Practice Case Series includes electronic access to:
MPORTANT NOTE: Since this product involves progression through a patient case over a period of time, it is highly recommended by the Editorial Board and past users, that you carve out 5 hours for the course and complete all in 1 sitting.
To satisfactorily complete the From Theory to Practice Case and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
You will proceed through the following steps to satisfactorily complete this course:
Credit is awarded in the calendar year the assessment is completed. AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Courtney Iuppa, PharmD, BCPP
View biographical information
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The From Theory to Practice Case Series product is an application-based program approved for 5 ACPE hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.
Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the From Theory to Practice Case Series upon successful completion of an online examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed.
The American Association of Psychiatric Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). This course is part of a 5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
2023 From Theory to Practice Case Series Editorial Board
|
Beth DeJongh, PharmD, BCPS, BCPP
Director of Continuing Professional Development
American Association of Psychiatric Pharmacists
Lincoln, NE
No Relevant Financial Relationships to Disclose
|
Megan J. Ehret, PharmD, BCPP, MS |
|
Karen E. Moeller, PharmD, BCPP Clinical Professor University of Kansas Kansas City, KS No Relevant Financial Relationships to Disclose |
Jill Reynoldson, PharmD, BCPP |
|
Brandy A. Singer, PharmD, BCPP Pharmacist Eastern State Hospital Medical Lake, WA No Relevant Financial Relationships to Disclose |
|
Rosana Steavenson, PharmD, BCPP, BCPS Program Manager, Mental Health Clinical Pharmacy Programs; Mental Health Clinical Pharmacy Specialist South Texas Veterans Health Care System San Antonio, TX No Relevant Financial Relationships to Disclose |
|
P. Brittany Vickery, PharmD, BCPP, BCPS Associate Professor of Pharmacy Wingate University School of Pharmacy / Advent Health Hendersonville Hendersonville, NC No Relevant Financial Relationships to Disclose |
All relevant relationships have been mitigated.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Presentation-Specific Disclosure: My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: Long-acting injectable antipsychotics for bipolar disorder
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
